MCID: SQM002
MIFTS: 49

Squamous Cell Papilloma

Categories: Cancer diseases, Oral diseases, Skin diseases

Aliases & Classifications for Squamous Cell Papilloma

MalaCards integrated aliases for Squamous Cell Papilloma:

Name: Squamous Cell Papilloma 12 15
Papilloma 44 72
Papilloma, Squamous Cell 72
Epidermoid Papilloma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:139
MeSH 44 D010212
NCIt 50 C3712
SNOMED-CT 68 63451008
UMLS 72 C0030354 C0205874

Summaries for Squamous Cell Papilloma

MalaCards based summary : Squamous Cell Papilloma, also known as papilloma, is related to carcinosarcoma and skin squamous cell carcinoma. An important gene associated with Squamous Cell Papilloma is CNTROB (Centrobin, Centriole Duplication And Spindle Assembly Protein), and among its related pathways/superpathways are Response to elevated platelet cytosolic Ca2+ and Pathways in cancer. The drugs Bethanechol and Cidofovir have been mentioned in the context of this disorder. Affiliated tissues include breast, skin and cervix, and related phenotypes are digestive/alimentary and renal/urinary system

Wikipedia : 75 A squamous cell papilloma is a generally benign papilloma that arises from the stratified squamous... more...

Related Diseases for Squamous Cell Papilloma

Diseases related to Squamous Cell Papilloma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 804)
# Related Disease Score Top Affiliating Genes
1 carcinosarcoma 29.4 TP53 HRAS
2 skin squamous cell carcinoma 29.3 TP53 HRAS
3 lung benign neoplasm 29.3 TP53 HRAS
4 cystadenocarcinoma 29.2 TP53 HRAS
5 pancreas disease 29.2 TP53 HRAS
6 nevus, epidermal 29.2 HRAS ATP2A2
7 suppression of tumorigenicity 12 28.3 TP53 HRAS
8 papilloma of choroid plexus 12.8
9 intraductal papilloma 12.5
10 esophagus squamous cell papilloma 12.5
11 squamous cell papilloma of skin 12.4
12 central breast papilloma 12.4
13 bladder transitional cell papilloma 12.4
14 skin papilloma 12.3
15 sclerosing breast papilloma 12.3
16 atypical breast papilloma 12.3
17 breast duct papilloma 12.3
18 transitional papilloma 12.3
19 atypical choroid plexus papilloma 12.3
20 ureter inverted papilloma 12.3
21 frontal sinus inverted papilloma 12.3
22 inverted transitional papilloma 12.3
23 nasal vestibule papilloma 12.3
24 maxillary sinus inverted papilloma 12.3
25 sphenoid sinus inverted papilloma 12.2
26 urinary bladder inverted papilloma 12.2
27 urethra inverted papilloma 12.2
28 serous surface papilloma 12.2
29 renal pelvis inverted papilloma 12.2
30 ethmoid sinus inverted papilloma 12.2
31 maxillary sinus schneiderian papilloma 12.2
32 cervix squamous papilloma 12.2
33 fallopian tube serous papilloma 12.2
34 vulvar squamous papilloma 12.2
35 nasal cavity inverting papilloma 12.2
36 vaginal mullerian papilloma 12.1
37 vaginal squamous papilloma 12.1
38 verrucous papilloma 12.1
39 frontal sinus schneiderian papilloma 12.1
40 ethmoid sinus schneiderian papilloma 12.1
41 ureter urothelial papilloma 12.1
42 sphenoid sinus schneiderian papilloma 12.1
43 cervical mullerian papilloma 12.1
44 bladder squamous papilloma 12.1
45 urethral urothelial papilloma 12.1
46 renal pelvis urothelial papilloma 12.1
47 ovarian surface papilloma 12.1
48 microscopic breast papilloma 12.1
49 larynx squamous papilloma 12.0
50 obsolete: deafness-white hair-contractures-papillomas syndrome 12.0

Graphical network of the top 20 diseases related to Squamous Cell Papilloma:



Diseases related to Squamous Cell Papilloma

Symptoms & Phenotypes for Squamous Cell Papilloma

MGI Mouse Phenotypes related to Squamous Cell Papilloma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.46 ATP2A2 BMP5 HRAS TP53
2 renal/urinary system MP:0005367 9.35 ATP2A2 BMP5 HRAS RASGRP1 TP53
3 respiratory system MP:0005388 8.92 ATP2A2 BMP5 HRAS TP53

Drugs & Therapeutics for Squamous Cell Papilloma

Drugs for Squamous Cell Papilloma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 273)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bethanechol Approved Phase 4 674-38-4 2370
2
Cidofovir Approved Phase 4 113852-37-2 60613
3
Polihexanide Approved, Investigational Phase 4 28757-47-3
4
Cantharidin Approved, Investigational Phase 4 56-25-7
5
Bleomycin Approved, Investigational Phase 4 11056-06-7 5360373
6 Muscarinic Agonists Phase 4
7 Disinfectants Phase 4
8 Chlorhexidine gluconate Phase 4
9 Anti-Infective Agents, Local Phase 4
10 Hypoglycemic Agents Phase 4
11 Biguanides Phase 4
12 Heptavalent Pneumococcal Conjugate Vaccine Phase 4
13 MF59 oil emulsion Phase 4
14 Vaccines Phase 4
15 Antiviral Agents Phase 4
16 Anti-Bacterial Agents Phase 4
17 Antibiotics, Antitubercular Phase 4
18 insulin Phase 4
19 Insulin, Globin Zinc Phase 4
20
Cevimeline Approved Phase 3 107233-08-9 25137844 83898
21
Fluconazole Approved, Investigational Phase 2, Phase 3 86386-73-4 3365
22
Miconazole Approved, Investigational, Vet_approved Phase 2, Phase 3 22916-47-8 4189
23
Megestrol acetate Approved, Investigational, Vet_approved Phase 3 595-33-5 11683
24
Histamine Approved, Investigational Phase 3 51-45-6 774
25
Azithromycin Approved Phase 3 83905-01-5 447043 55185
26
Promethazine Approved, Investigational Phase 3 60-87-7 4927
27
Diphenhydramine Approved, Investigational Phase 3 58-73-1, 147-24-0 3100
28
Doxepin Approved, Investigational Phase 3 1668-19-5 667477 667468
29
Penicillin G Approved, Vet_approved Phase 3 61-33-6 5904
30
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
31
Zinc Approved, Investigational Phase 3 7440-66-6 32051
32
Zinc sulfate Approved, Investigational Phase 3 7733-02-0
33
Cetuximab Approved Phase 3 205923-56-4 56842117 2333
34
acetic acid Approved Phase 3 64-19-7 176
35 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
36 Analgesics Phase 3
37 Peripheral Nervous System Agents Phase 3
38 Neurotransmitter Agents Phase 3
39 14-alpha Demethylase Inhibitors Phase 2, Phase 3
40 Cytochrome P-450 CYP2C9 Inhibitors Phase 2, Phase 3
41 Cytochrome P-450 Enzyme Inhibitors Phase 2, Phase 3
42 Antifungal Agents Phase 2, Phase 3
43 Steroid Synthesis Inhibitors Phase 2, Phase 3
44 Hormone Antagonists Phase 2, Phase 3
45 Cytochrome P-450 CYP2C19 Inhibitors Phase 2, Phase 3
46 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3
47 Contraceptives, Oral Phase 3
48 Central Nervous System Stimulants Phase 3
49 Antineoplastic Agents, Hormonal Phase 3
50 Appetite Stimulants Phase 3

Interventional clinical trials:

(show top 50) (show all 450)
# Name Status NCT ID Phase Drugs
1 Intralesional Measles, Mumps, Rubella (MMR) Vaccine Versus Cryotherapy in Treatment of Multiple Common and Planter Warts : a Randomized Controlled Trial Unknown status NCT03183765 Phase 4 Measles-Mumps-Rubella Vaccine
2 Effectiveness of Bethanechol Chloride and Early Bladder Training for Prevention of Bladder Dysfunction After Radical Hysterectomy in Cervical Cancer Stage IB - IIA Unknown status NCT02910596 Phase 4 bethanechol chloride
3 Immunogenicity Of A Prophylactic Quadrivalent Human Papillomavirus (Types 6, 11, 16, And 18) L1 Virus-Like Particle Vaccine In Male And Female Adolescent Transplant Recipients. Unknown status NCT01101750 Phase 4
4 Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients Unknown status NCT02624349 Phase 4 Quadravalent human papillomavirus vaccine
5 A Phase IV, Randomised Study to Evaluate the Immune Responses of UK Adolescent Girls Receiving CervarixTM or GardasilTM Human Papillomavirus Vaccines Completed NCT00956553 Phase 4
6 Use of Cidofovir Injection in the Treatment of Recurrent Respiratory Papillomatosis." Completed NCT00205374 Phase 4 Cidofovir;Placebo
7 Antisepsis Regimen in the Surgical Treatment of Human Papilloma Virus Generated Cervical Lesions: Polyhexamethylene Biguanide Versus Chlorhexidine Completed NCT01740245 Phase 4
8 Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate Vaccine After Concomitant Vaccination in ≥50-year-old Adults Completed NCT03552445 Phase 4
9 Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease Completed NCT01034358 Phase 4
10 Trichloroacetic Acid Versus Cantharone for the Treatment of Perenial Warts Completed NCT03625960 Phase 4 Cantharidin;Trichloroacetic Acid
11 Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13) and MF59-adjuvanted Influenza Vaccine (Fluad) After Concomitant Vaccination in Adults Aged ≥60 Years Completed NCT02215863 Phase 4
12 Immunogenicity and Safety of MF59-adjuvanted Trivalent Influenza Vaccine (Fluad) and 23-valent Pneumococcal Polysaccharide Vaccine (PPV23) in the Elderly: Single Versus Concomitant Vaccination Completed NCT02225327 Phase 4
13 Quadrivalent HPV Vaccination After Effective Treatment of Anal Intraepithelial Neoplasia in HIV+ Men Completed NCT02087384 Phase 4 Placebo
14 Occupational Exposure to Human Papilloma Virus (HPV) and Prophylactic Vaccination (Version IV Dated 24Oct2017) Recruiting NCT03350698 Phase 4
15 GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose Recruiting NCT03943875 Phase 4
16 Prospective Longitudinal Study on Immunogenicity, Induction of Cellular Immune Responses and Safety of Vaccination Against HPV With the 9-valent Vaccine in HIV-positive Women (The Papillon Study) Recruiting NCT03391921 Phase 4
17 A Scientific Evaluation of One or Two Doses of Vaccine Against Human Papillomavirus: the ESCUDDO Study Recruiting NCT03180034 Phase 4
18 The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts Not yet recruiting NCT03477448 Phase 4 Bleomycin;Purified Protein Derivative
19 Assessment of the Safety, Side Effects and Efficacy of Interventional Cryotherapy for the Eradication of Benign Airway Disease("ICE THE BAD") Terminated NCT00747461 Phase 4
20 Anal Dysplasia Study of Men Who Have Sex With Men Living With HIV Withdrawn NCT01663558 Phase 4 imiquimod
21 Evaluation of a Two-dose Schedule of Quadrivalent Human Papilloma Virus (Types 6, 11, 16, 18) Recombinant Vaccine in 11-year-old Boys in Mexico City (Gardasil® Merck and Co.). Unknown status NCT02382900 Phase 3
22 Comparison Between Tuberculin Vaccine and Cryotherapy in the Treatment of Genital Wart Patients Unknown status NCT03153566 Phase 3
23 Phase III, Single-center Clinical Trial to Evaluate the 4-valent HPV Vaccine for the Treatment and Prevention of Recurrent Respiratory Papillomatosis in Children Unknown status NCT01995721 Phase 3
24 Cryotherapy Versus Laser for the Treatment of Nongenital Cutaneous Warts: A Randomized Controlled Clinical Trial Unknown status NCT01808443 Phase 3
25 Trial of Male Circumcision: HIV, STD and Behavioral Effects in Men, Women and the Community Unknown status NCT00124878 Phase 3
26 A Phase III Placebo-controlled Clinical Trial to Study the Tolerability, Immunogenicity and Efficacy of V501 in 16- to 26-year-old Japanese Men Completed NCT01862874 Phase 3
27 Prospective Non Controlled Study of Immunogenicity of Human Papilloma Virus (HPV) Vaccine in Groups at Special Risk of Poor Vaccine Result Completed NCT00964210 Phase 3 Licensed quadrivalent HPV vaccine, Gardasil
28 Evaluation of Safety, Tolerability and Immunogenicity of Quadrivalent HPV Vaccine in Healthy Females 9 to 15 Years of Age in India Completed NCT00380367 Phase 3
29 A Randomized, Double-Blinded, Controlled With GARDASIL (Human Papillomavirus Vaccine [HPV] [Types 6, 11, 16, 18] (Recombinant, Adsorbed)), Phase 3 Clinical Trial to Study the Immunogenicity and Tolerability of V503 (9-Valent Human Papillomavirus L1 Virus-Like Particle [VLP] Vaccine) in 16- to 26-year-old Men Completed NCT02114385 Phase 3
30 A Phase III, Open-Label, Clinical Trial to Study the Safety and Immunogenicity of the Quadrivalent HPV (Types 6, 11, 16, 18) L1 VLP Particle (VLP) Vaccine in 9- to 15-Year-Old Japanese Boys Completed NCT02576054 Phase 3
31 A Phase III Open-label, Safety, Tolerability and Immunogenicity Study of a 9-Valent Human Papillomavirus (HPV) L1 Virus-Like Particle (VLP) Vaccine Administered to 9- to 15-Year-Old Japanese Preadolescent and Adolescent Girls Completed NCT01254643 Phase 3
32 Phase IIIb Study of Recombinant Tetravalent HPV Vaccine in Patients With Recurrent Respiratory Papillomatosis Completed NCT01375868 Phase 3
33 Immunogenicity and Safety Study of a Bivalent Human Papillomavirus (Type 16, 18) Recombinant Vaccine (E.Coli) in Healthy Female Subjects Aged 9 to 17 Years Completed NCT02562508 Phase 3
34 A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Cevimeline in the Treatment of Xerostomia Secondary to Radiation Therapy for Cancer in the Head and Neck Region Completed NCT00017511 Phase 3 cevimeline hydrochloride
35 A PHASE II/III PILOT STUDY OF THE EFFECTS OF PROPHYLACTIC FLUCONAZOLE THERAPY ON MUCOSITIS IN PATIENTS UNDERGOING RADIATION TREATMENT FOR HEAD AND NECK CANCER Completed NCT00002533 Phase 2, Phase 3 fluconazole
36 A Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts Completed NCT00735462 Phase 3 2.5% imiquimod cream;3.75% imiquimod cream;Placebo cream
37 A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Amolimogene (ZYC101a) in the Treatment of High-Grade Cervical Intraepithelial Lesions (CIN 2/3) of the Uterine Cervix Completed NCT00264732 Phase 2, Phase 3 Amolimogene;Amolimogene
38 Evaluate the Safety and Immunogenicity of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly According to a 0,1,6 Month Schedule in Healthy Female Subjects (10 - 14 Years) Completed NCT00196924 Phase 3
39 Immunogenicity: 3 Consecutive Lots of GSK Biologicals' HPV-16/18 Vaccine Administered Intramuscularly at 0,1,6 Month Schedule in Healthy Females Aged 10-25 Years and Demonstrate Non-inferiority of Candidate HPV Vaccine Manufactured by Modified Production Process Completed NCT00169494 Phase 3
40 A Phase III, Double-Blind, Randomized Study Of The Effect Of Megestrol Acetate On Weight And Health Related Quality Of Life In Head And Neck Cancer Patients Receiving Radiation Therapy Completed NCT00006799 Phase 3 megestrol acetate
41 A Safety and Immunogenicity Study of Quadrivalent HPV (Types 6, 11, 16, 18) L1 Virus-Like Particle (VLP) Vaccine in Preadolescents and Adolescents (Base Study). A Long Term Immunogenicity, Safety, and Effectiveness Study of GARDASIL (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) Among Adolescents Who Received GARDASIL at 9-18 Years of Age (Extension Study). Completed NCT00092547 Phase 3
42 Topical Imiquimod in Treating Patients With Grade 2/3 Cervical Intraepithelial Neoplasia Completed NCT00941252 Phase 2, Phase 3 Topical imiquimod therapy
43 Acupuncture for Pain and Dysfunction Following Neck Dissection: A Randomized, Controlled, Phase III Trial Completed NCT00090337 Phase 3
44 Safety, Immunogenicity, and Efficacy of Gardasil (V501 (Human Papilloma Virus [Types 6, 11, 16, 18] Recombinant Vaccine) in Mid-Adult Women - The FUTURE III (Females United to Unilaterally Reduce Endo/Ectocervical Cancer) Study Completed NCT00090220 Phase 3
45 A Phase III, Double-blind, Randomized, Controlled, Multi-center Study to Evaluate the Efficacy of GlaxoSmithKline Biologicals. HPV-16/18 VLP AS04 Vaccine Compared to Hepatitis A Vaccine as Control in Prevention of Persistent HPV-16 or HPV-18 Cervical Infection and Cervical Neoplasia, Administered Intramuscularly According to a 0, 1, 6 Month Schedule in Healthy Females 15-25 Years of Age. Completed NCT00122681 Phase 3
46 A Long-term, Open, Follow-up of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV-16/18 L1/AS04 Vaccine in Healthy Female Subjects Vaccinated Either Pre- or Post-menarche in the Primary Study Completed NCT00337818 Phase 3
47 A Randomized Clinical Trial of Infrared Coagulator (IRC) Ablation Versus Expectant Management of Intra-Anal High Grade Intraepithelial Neoplasia (HGAIN) in HIV-infected Adults Completed NCT01164722 Phase 3
48 A Phase III Randomized Study of 5-Fluorouracil, Mitomycin-C, and Radiotherapy Versus 5-Fluorouracil, Cisplatin, and Radiotherapy in Carcinoma of the Anal Canal Completed NCT00003596 Phase 3 cisplatin;fluorouracil;mitomycin C
49 A Randomized Double-Blind Study of Doxepin Rinse Versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy Completed NCT01156142 Phase 3 doxepin hydrochloride
50 Effect of WHO-yaws Elimination Strategy in Lihir Island, Papua New Guinea Completed NCT01955252 Phase 3 Azithromycin

Search NIH Clinical Center for Squamous Cell Papilloma

Inferred drug relations via UMLS 72 / NDF-RT 51 :


podophyllin
PODOPHYLLIN PWDR

Cochrane evidence based reviews: papilloma

Genetic Tests for Squamous Cell Papilloma

Anatomical Context for Squamous Cell Papilloma

MalaCards organs/tissues related to Squamous Cell Papilloma:

41
Breast, Skin, Cervix, Testes, T Cells, Brain, Lung

Publications for Squamous Cell Papilloma

Articles related to Squamous Cell Papilloma:

(show top 50) (show all 13455)
# Title Authors PMID Year
1
Feasibility of transnasal flexible carbon dioxide laser surgery for laryngopharyngeal lesions. 38
30765273 2019
2
Attachment-oriented endoscopic surgical management for inverted papillomas in the nasal cavity and paranasal sinuses. 38
30833129 2019
3
Variability in the Management Recommendations Given for High-risk Breast Lesions Detected on Image-guided Core Needle Biopsy at U.S. Academic Institutions. 38
30075881 2019
4
Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. 38
31041828 2019
5
Papilloma of the Fallopian Tube: A Rare Gynecologic Neoplasm Harboring a BRAF (c.1799T>A) Mutation (V600E). 38
29851866 2019
6
Viral suspicions: Vaccine hesitancy in the Web 2.0. 38
30816729 2019
7
Is core needle biopsy effective at diagnosing male breast lesions? 38
31168757 2019
8
Positive margin rates and predictors in transoral robotic surgery after federal approval: A national quality study. 38
31058417 2019
9
Thin variant of high-grade squamous intraepithelial lesion - relationship with high-risk and possibly carcinogenic human papilloma virus subtypes and somatic cancer gene mutations. 38
30927371 2019
10
Distinct mutational landscape of inverted urothelial papilloma. 38
31119740 2019
11
Dietary Inflammatory Index and Its Relationship with Cervical Carcinogenesis Risk in Korean Women: A Case-Control Study. 38
31382563 2019
12
ATR inhibition sensitizes HPV- and HPV+ head and neck squamous cell carcinoma to cisplatin. 38
31345392 2019
13
Respiratory epithelial adenomatoid hamartoma: a diagnostic challenge in sinonasal lesions. 38
31383684 2019
14
Lymphangiofibrolipomatous hamartomaous polyp of tonsil. 38
31391168 2019
15
Gallbladder Papilloma in a Child Unmasking Metachromatic Leukodystrophy: A Case Report With Review of Literature. 38
30912695 2019
16
Choroid plexus papilloma of the third ventricle. A case report. 38
31401052 2019
17
Histogram Analysis Parameters ADC for Distinguishing Ventricular Neoplasms of Ependymoma, Choroid Plexus Papilloma, and Central Neurocytoma. 38
31390342 2019
18
Pigmented primary epithelial tumor of the sella: A report of an intriguing case. 38
31373070 2019
19
DNA methylation signature is prognostic of choroid plexus tumor aggressiveness. 38
31409384 2019
20
Analysis of the Clinical Relevance of Histological Classification of Benign Epithelial Salivary Gland Tumours. 38
31209701 2019
21
Canine papillomavirus types 1 and 2 in classical papillomas: High abundance, different morphological associations and frequent co-infections. 38
31383413 2019
22
Benign breast papillary lesions diagnosed on core biopsy: upgrade rate and risk factors associated with malignancy on surgical excision. 38
31372738 2019
23
Use of a trans-tracheal rapid insufflation of oxygen device in a "cannot intubate, cannot oxygenate" scenario in a parturient -a case report. 38
30776879 2019
24
Cervical intraepithelial neoplasia grade 3 in a patient following Gardasil vaccination. 38
31401577 2019
25
Update on Neuroendocrine Carcinomas of the Larynx. 38
31415081 2019
26
Comparison Between Endoscopic Prelacrimal Medial Maxillectomy and Caldwell-Luc Approach for Benign Maxillary Sinus Tumors. 38
30458603 2019
27
An audit of mammographic screen detected lesions of uncertain malignant potential (B3) diagnosed on initial image guided needle biopsy: how has our practice changed over 10 years? 38
31078275 2019
28
2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. 38
31413005 2019
29
Familial Clustering, Second Primary Cancers and Causes of Death in Penile, Vulvar and Vaginal Cancers. 38
31413311 2019
30
Sinonasal inverted papilloma associated with small cell neuroendocrine carcinoma: A case report and literature review of rare malignancies associated with inverted papilloma. 38
30545727 2019
31
The Frequency of Human Papilloma Virus in Laryngeal Squamous Cell Carcinoma. 38
31358108 2019
32
Effects of tobacco abuse on major chromosomal instability in human papilloma virus 16-positive oropharyngeal squamous cell carcinoma. 38
31268157 2019
33
Benign Breast Papilloma without Atypia: Outcomes of Surgical Excision versus US-guided Directional Vacuum-assisted Removal or US Follow-up. 38
31429678 2019
34
Effects of HVP Status on Responsiveness to Ionizing Radiation vs. Photodynamic Therapy in Head and Neck Cancer Cell lines. 38
31408910 2019
35
Intralesional injection of vitamin D3 versus zinc sulfate 2% in treatment of plantar warts: a comparative study. 38
31415213 2019
36
NOVA1 induction by inflammation and NOVA1 suppression by epigenetic regulation in head and neck squamous cell carcinoma. 38
31375778 2019
37
Human Papillomavirus 16 oncoprotein E7 retards mitotic progression by blocking Mps1-MAP4 signaling cascade. 38
31253867 2019
38
Inosine Pranobex: A Key Player in the Game Against a Wide Range of Viral Infections and Non-Infectious Diseases. 38
31168764 2019
39
Prevalence and characteristics of HPV-driven oropharyngeal cancer in France. 38
31158796 2019
40
Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation. 38
31345397 2019
41
Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment. 38
31113825 2019
42
Trends and targets in antiviral phototherapy. 38
31397467 2019
43
Periodontal pathogens are a risk factor of oral cavity squamous cell carcinoma, independent of tobacco and alcohol and human papillomavirus. 38
30671943 2019
44
Human papilloma virus DNA-biomarker analysis for cervical cancer: Signal enhancement by gold nanoparticle-coupled tetravalent streptavidin-biotin strategy. 38
31078598 2019
45
Flax seed oil reduced tumor growth, modulated immune responses and decreased HPV E6 and E7 oncoprotein expression in a murine model of ectopic cervical cancer. 38
30959179 2019
46
The E6/E7 oncogenes of human papilloma virus and estradiol regulate hedgehog signaling activity in a murine model of cervical cancer. 38
31125556 2019
47
Altered microRNA processing proteins in HPV-induced cancers. 38
31408800 2019
48
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer. 38
31088830 2019
49
Dental students' awareness and attitudes toward HPV-related oral cancer: a cross sectional study at the University of Jordan. 38
31370845 2019
50
The changing landscape of head and neck cancer radiotherapy patients: is high-risk, prolonged feeding tube use indicative of on-treatment weight loss? 38
31385650 2019

Variations for Squamous Cell Papilloma

Cosmic variations for Squamous Cell Papilloma:

9
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM13702 CDKN2A upper aerodigestive tract,larynx,other,papilloma c.293A>G p.H98R 9:21971066-21971066 0

Expression for Squamous Cell Papilloma

Search GEO for disease gene expression data for Squamous Cell Papilloma.

Pathways for Squamous Cell Papilloma

GO Terms for Squamous Cell Papilloma

Biological processes related to Squamous Cell Papilloma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 negative regulation of cell proliferation GO:0008285 9.61 TP53 HRAS BMP5
2 positive regulation of JNK cascade GO:0046330 9.46 RASGRP1 HRAS
3 positive regulation of MAP kinase activity GO:0043406 9.4 RASGRP1 HRAS
4 positive regulation of epithelial cell proliferation GO:0050679 9.37 HRAS BMP5
5 intrinsic apoptotic signaling pathway GO:0097193 9.32 TP53 HRAS
6 cellular response to gamma radiation GO:0071480 9.26 TP53 HRAS
7 cell aging GO:0007569 9.16 TP53 HRAS
8 positive regulation of Ras protein signal transduction GO:0046579 8.96 RASGRP1 HRAS
9 Ras protein signal transduction GO:0007265 8.8 TP53 RASGRP1 HRAS

Sources for Squamous Cell Papilloma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....